C
Century Therapeutics, Inc. (IPSC)
NCM – Real Time Price. Currency in USD
2.32
+0.02 (0.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.36
+0.04 (1.72%)
After-hours: Jun 26, 2026, 6:51 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.32
+0.02 (0.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.36
+0.04 (1.72%)
After-hours: Jun 26, 2026, 6:51 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $51.4M significantly exceed its total debt $48.0M, ensuring strong financial flexibility
Total current assets $139.0M exceed Total current liabilities $13.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$25.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.25 | 6.05 | 10 | |
| Quick ratio | 10.25 | 5.63 | 10 | |
| Debt to Equity | 0.18 | 0.30 | 9.0 | |
| Debt to Assets | 0.15 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5M | 2M | 7M | 109M | N/A |
| Gross Profit | -5M | -11M | -7M | 96M | -13M |
| Operating Income | -124M | -125M | -134M | -15M | -114M |
| Net Income | -131M | -137M | -127M | -10M | -108M |
| EBITDA | -114M | -112M | -121M | -2M | -102M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 71.05 | 5.5 |
| Next quarter | N/A | 71.56 | 5.5 |
| Current year | -100 | -224.6 | 1.0 |
| Next year | N/A | 3.16 | 2.5 |
| Weighted average score | 3.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -12.89 | 56 | -62.03 | 5.5 |
| Y/Y | -99.99 | -128.26 | -112.35 | 26.42 | 3.3 |
| 3y average | 564.86 | 31.82 | 40 | -167.53 | 7.8 |
| 5y average | 738.51 | -3.99 | 35.83 | -115.79 | 5.5 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |